Fluent Biosciences careers
Fluent Biosciences provides enabling technology for liquid biopsy - cancer detection from blood samples - and related applications. Pre-templated Instant Partitions (PIPs) enable near-instantaneous capture and partitioning of individual molecules into millions of consistent reactions. We have shown this enables extremely sensitive and unbiased preparation of nucleic acids for DNA sequencing. Fluent's proprietary reagents provide single-molecule sensitivity without sequence bias and do not require complex user-side instrumentation or consumables. Therefore, it is faster and cost lower than existing solutions.
See pub: Particle-templated emulsification for microfluidics-free digital biology
biorxiv.org/content/early/2018/04/19/304923
See pub: Particle-templated emulsification for microfluidics-free digital biology
biorxiv.org/content/early/2018/04/19/304923
Fluent Biosciences hasn't added any jobs yet
Get notified when Fluent Biosciences posts new jobs.
Sepehr Kiani
President and CEO Fluent BioSciences. Formerly VP/GM Bio-Rad, EVP GnuBIO, Dir Eng Helicos BioSciences, and Product Manager Teradyne. Education: Ph.D., MIT
Gary Zweiger
Founder Fluent Biosciences • Worked at @Life. Tech, @Agilent Technologies • Studied at @Stanford University, @Stanford University University School of Medicine
Bill Hyun
Investor/Founder Vitra Bio, Charisela Bio, Accuri Cytometers, True Materials, BioTrue, Immusoft, Symbiosys Biowares, Fibralign, Newbridge Media, SEQ, Cytobank
Adam Abate
Valuation
$0
Funded over
1 round
Latest round
